Page 3 - Human Pharma News Today

SINGAPORE, Jan. 18, 2024 /PRNewswire/ -- Boehringer Ingelheim has been awarded "Global Top Employer" for the fourth year in a row, and one of the 17 globally

Boehringer’s employer offerings receive particularly high scores in the categories “Develop” and “Steer” pointing out a link between individual development and the company purpose of transforming lives for generations. The internal Boehringer Ingelheim University is a key element in this. It includes a ...

YOUNG people were given a taste of life after college as the Young Person Employablity Partnership: Sharing Skills for Life event returned.

Ingelheim: Boehringer Ingelheim, a research-driven biopharmaceutical company, has announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the...

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications, some of them in the late-stage ...

/PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure AB (Ribo) today announced a collaboration with Boehringer Ingelheim to develop novel treatments...

/PRNewswire/ -- The Scleroderma Research Foundation (SRF), the nations largest non-profit funder of scleroderma research, today announced that the FDA has...

Over 140 healthcare professionals from the Middle East and Africa gathered for the third edition of the Interstitial Lung Disease (ILD) Summit to discuss the latest developments in the treatment and management of respiratory conditions.

TORONTO & WALTHAM, Mass.--(BUSINESS WIRE)--Nov 29, 2023--

Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development of efficient therapeutics.